ALBEMARLE CORP ALB
NYSE · XNYS · stock · Plastic Materials, Synth Resins & Nonvulcan Elastomers · website · IPO 1994-02-22
ALBEMARLE CORP financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.1B | $5.4B | $9.6B | $7.3B | $3.3B |
| Gross profit | $668.7M | $62.5M | $1.2B | $3.1B | $998.0M |
| R&D expense | $51.4M | $86.7M | $85.7M | $72.0M | $54.0M |
| SG&A expense | $550.0M | $618.0M | $910.0M | $524.1M | $441.5M |
| Operating income | -$367.1M | -$1.8B | $251.9M | $2.5B | $798.4M |
| Income tax | $156.9M | $87.1M | $430.3M | $390.6M | $29.4M |
| Net income | -$510.6M | -$1.2B | $1.6B | $2.7B | $123.7M |
| EPS (diluted) | $-5.76 | $-11.20 | $13.36 | $22.84 | $1.06 |
| Operating cash flow | $1.3B | $687.9M | $1.3B | $1.9B | $344.3M |
| Free cash flow | $692.5M | -$992.7M | -$828.0M | $650.8M | -$609.4M |
| Cash & equivalents | $1.6B | $1.2B | $889.9M | $1.5B | $439.3M |
| Inventory | $1.2B | $1.5B | $2.2B | $2.1B | $798.6M |
| Total assets | $16.4B | $16.6B | $18.3B | $15.5B | $11.0B |
| Shareholders' equity | $9.8B | $10.2B | $9.7B | $8.2B | $5.8B |
Source: SEC EDGAR filings · CIK 0000915913 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.